Long-term results of vagus nerve stimulation in refractory epilepsy
|
|
- Ginger Kennedy
- 5 years ago
- Views:
Transcription
1 Seizure 1999; 8: Article No. seiz , available online at on MILLENIUM GOWER PRIZE ENTRY Long-term results of vagus nerve stimulation in refractory epilepsy K. VONCK, P. BOON, M. D HAVÉ, T. VANDEKERCKHOVE, S. O CONNOR & J. DE REUCK Epilepsy Monitoring Unit, Department of Neurology and; Department of Neurosurgery, University Hospital Gent, Belgium; Cyberonics Europe, Zaventem, Belgium Vagus nerve stimulation (VNS) is an adjunctive antiepileptic treatment for patients with refractory epilepsy. Limited information on long-term treatment with VNS is available. The purpose of this paper is to present our experience with VNS with a follow-up of up to 4 years. Twenty-five patients (13 females and 12 males) with refractory partial epilepsy were treated with VNS. The first 15 patients with a mean age of 30 years and a mean duration of epilepsy of 17.5 years have sufficient follow-up for analysis. Mean post-implantation follow-up was 29 months and mean stimulation output 2.25 ma. There was a mean seizure frequency reduction from 14 complex partial seizures (CPS) per month before implantation to 8 CPS per month after implantation (P = ; Wilcoxon signed-rank rest (WSRT)). The mean maximum CPS-free interval changed from 9 to 312 days (P = ; WSRT). Six patients were free of CPS for at least one year. In one patient, one antiepileptic drug (AED) was tapered; in 10 patients, AEDs remained unchanged; in four, one adjunctive AED was administered. Side effects occurred in six patients, three of whom required a temporary reduction of output current. Nine patients reported no side effects at all. Treatment with VNS remains effective in the long-term. In this series 4/15 (27%) patients with highly refractory epilepsy experienced entirely seizure-free intervals of 12 months or more. Key words: vagus nerve stimulation; long-term treatment; refractory epilepsy; epilepsy surgery; complex partial seizures; seizure-free. INTRODUCTION Approximately 1% of the population suffers from chronic epilepsy. Partial epilepsy is the most common type of epilepsy in adults 1. According to the literature, about 20% of patients with epilepsy have uncontrolled or poorly controlled seizures despite adequate treatment with antiepileptic drugs (AEDs) 2. For these patients, epilepsy surgery may represent a therapeutic alternative. This requires a thorough patient selection and only 30 50% of patients can be operated on after extensive pre-surgical evaluation 3. Implantation with a vagus nerve stimulator is a novel and currently available antiepileptic treatment modality for the remaining patients. Worldwide, more than 3500 patients have been implanted and several mostly short-term studies on efficacy and safety have been published 4 8. The current consensus is that a third of patients experience a considerable improvement in seizure control with a reduction in seizure frequency of at least 50%, a third of patients experience a worthwhile reduction of seizure frequency between 30 and 50%. In the remaining third of the patients, there is little or no effect. Currently limited information is available on patients with refractory partial epilepsy who became seizure-free during vagus nerve stimulation (VNS) 16, 17. There are no studies that evaluate the clinical, neuroimaging and EEG features of seizure-free patients treated with VNS. The purpose of this paper is to evaluate seizure control in 15 implanted patients with long-term follow-up and to describe in detail the case reports of three out of four patients who experienced long-term ( 12 months) entirely seizure-free intervals /99/ $12.00/0 c 1999 BEA Trading Ltd
2 Long-term results of vagus nerve stimulation 329 MATERIALS AND METHODS At the University Hospital in Gent, 25 patients (12 females and 13 males) have been implanted with a VNS between March 1995 and April These patients were part of a larger group (n = 150) of patients with medically refractory epilepsy who were included in a pre-surgical evaluation protocol. After video- EEG monitoring, optimum MRI, interictal FDG-PET and neuropsychological assessment, 105/150 patients were found to be unsuitable candidates for resective surgery. In some patients, a confined and resectable epileptic zone could not be identified; in others, resective surgery was contraindicated because of the fear of a possible post-operative cognitive deficit. These patients were offered three alternatives: rematching of standard AEDs, drug-trials with novel AEDs or VNS. Fifty patients continued their medical treatment and had a rematching of standard AEDs, 30 patients were included in phase-3 drug trials with novel AEDs such as topiramate, gabapentin or levetiracetam. Twentyfive patients were offered implantation of a vagus nerve stimulator and gave informed consent. The local ethics committee approved the VNS implantation and study protocol. The first 15 patients (6M, 9F) have sufficient follow-up data for analysis and will be further discussed in this study. Mean follow-up in these 15 patients was 29 months (range 12 48; SD = 11.9). Six out of fifteen patients have a follow-up of 1 2 years; 5/15 have a follow of 2 3 years; 4/15 have a followup of 3 4 years. The mean age of these patients was 30 years (range: years; SD = 7.9); the mean duration of epilepsy was 17.5 years (range: 5 35 years; SD = 8.5). All patients but one were on chronic anticonvulsant polytherapy, the mean number of AEDs being 3 (range 1 4; SD = 0.8). Stimulation of the left vagus nerve was performed using the Neurocybernetic Prosthesis (NCP R ) System (Cyberonics Inc., Houston Texas) that comprises two components: the NCP R (a generator which is implanted subcutaneously in a subclavicular pouch) and the NCP R -lead with two spiral electrodes that are wound around the left vagus nerve in the neck. The surgical procedure, described previously 9 11, requires general anaesthesia and takes about 1 hour. Patients were discharged 24 hours after surgery. Stimulation was initiated within 2 4 weeks after surgery. The generator was programmed using a portable computer provided with a programming device and specialized software. The programming device was held upon the patient s chest above the implanted generator to program the various stimulation parameters such as output current, frequency, pulse-width and on/off periods. During follow-up clinic visits, the output current was gradually ramped up with ma per visit until individual patient tolerance or a maximum of 3 ma was reached. The other parameters were programmed according to standard stimulation with a frequency of 30 Hz, pulse width of 500 µs, on/off periods of 30 s/ s. The patients were also provided with a magnet allowing additional stimulation to be commanded by the patient or a bystander in the case of an aura or seizure. The magnet output current was programmed at 0.25 ma higher than the automatically delivered stimulation with a pulse width of 500 µs for a period of 30 s. Standard stimulation was replaced by rapid cycle stimulation (on/off periods = 7 s/14 s) in patients who did not respond to standard stimulation parameters. This has been shown to be effective in some patients 12. Patients were followed on an outpatient basis at regular intervals, usually every 2 4 weeks during ramping up. Afterwards patients were seen every 1 3 months for further follow-up. At every clinic visit, seizure frequency, seizure type, prescribed AEDs and dosage as well as any side effects of VNS were assessed. In every patient, we prospectively assessed the decrease of seizure frequency in relation to stimulation output current and type (standard vs. rapid cycle), seizure type(s) suppressed by VNS, change in duration of seizures, and duration of seizurefree intervals. Seizure frequency during the year before and the full follow-up period after the day of implantation was compared using the Wilcoxon signedrank test (WSRT). Using the same statistical test, we also compared the maximum complex partial seizures (CPS)-free days in the year before VNS and follow-up time after VNS. Because of difficulties in accountability, simple partial seziures (SPS) were not included in this analysis. RESULTS In all 15 patients the surgical procedure was uncomplicated and the post-operative period was uneventful. The patients were discharged from the hospital 24 hours after surgery. After ramping up during 2 4 months, mean stimulation output was 2.25 ma (range ma; SD = 0.6). Usually, the occurrence of coughing and/or an unpleasant sensation in the throat was the limiting factor for further increasing the output current. During follow-up, the patients showed a mean reduction in CPS frequency from 14 seizures per month (range: 2 40 per month; SD = 13.8) to 8 seizures per month (range: 0 30 per month; SD = 12.1). This reduction is statistically significant ( P = ; WSRT). One patient showed clusters of up to 10 CPS a day (200 seizures per month) and had a clear-cut reduction of this seizure frequency. This patient was not included in the analysis for statistical reasons. Six patients were free from CPS during a 12-month interval. Four our of six patients experienced an entirely seizure-free interval of 12 months or more. Two out
3 330 K. Vonck et al. of six patients still have SPS but stopped having CPS within 3 months after stimulation initiation. Four other patients had a seizure reduction of more than 50%; two patients had a worthwhile reduction of seizure frequency between 30 50%; in three patients, seizure reduction was less than 30% or seizure frequency remained unchanged. A reduction in seizure frequency of 50% was achieved within the first 4 months after initiation of stimulation in 8/10 patients, amongst whom were all six patients with seizure-free intervals of 12 months. At the time of evaluation, 6/13, who frequently had secondary generalized tonic clonic seizures before implantation, were free of convulsions. Five out of seven patients who still experience secondary generalization have had a 50% reduction in frequency and/or duration of convulsions. The mean maximum complex partial seizurefree interval changed from 9 days (range: 1 30 days; SD = 8.1) to 312 days (range: days; SD = 469.1). This change in seizure-free interval is statistically significant ( P = ; WSRT). Patients with a 50% reduction of seizure frequency had a mean pre-implantation seizure frequency of 5.9 vs. 13, 7 (n.s.; P = ) in the total population. The number and average dosage of AEDs remained unchanged in 10 patients. In one patient, tapering of two AEDs reduced polytherapy but in four patients one adjunctive AED had to be administered. Three out of four patients that are currently free from all types of seizures never had any change of AED treatment. One out of four had a trial with vigabatrin and later on with lamotrigine. Two patients who are free from CPS but still experience SPS had trials with novel AEDs without additional benefit regarding the occurrence of SPS. At the first stimulation with 0.25 ma output current, almost all patients reported a funny and indescribable sensation in the throat, as if they were to swallow. Each time the output was gradually increased, this sensation reoccurred and subsided spontaneously within 48 hours. This throat sensation was considered a minor and intrinsic side effect causing no pain or real discomfort. Six patients reported true side effects. Two of these patients complained of mild intermittent hoarseness or voice alteration during stimulation and one patient experienced dysphagia at the time of stimulation. These side effects did not require any change of stimulation output and subsided over a time period of several weeks. However, three patients reported persistent coughing and additional unpleasant chest, throat or neck sensations during the ramping-up period. This required a temporary reduction of the output current but none of the patients requested that the stimulation be turned off. Nine patients did not report any side effects at all. CASE-REPORT # 1 UP is a 36-year-old right-handed male who suffered from epilepsy since age 11. He had complicated febrile seizures as a toddler. At age eight, he experienced a severe head trauma with subsequent coma lasting 4 months. At age 11, he started having CPS consisting of a rising epigastric sensation followed by impairment of consciousness and semipurposeful behaviour. From adolescence on, these seizures frequently evolved into secondary generalization. At the time of evaluation he had at least two secondary generalized seizures per week. After extensive trials with all available AEDs in various combinations including vigabatrin and lamotrigine, the patient was evaluated for epilepsy surgery. Video-EEG monitoring confirmed the existence of partial seizures with strikingly fast secondary generalization. Neither were there clinically lateralizing features, nor could the ictal EEG be lateralized. Interictal EEG showed bilateral independent epileptic discharges and no consistent focus. Optimum MRI showed bilateral hippocampal atrophy, more obvious on the right side. FDG-PET revealed widespread right temporal hypometabolism. Neuropsychological testing showed a mild mental retardation and severe psychological instability. The patient was considered unable to cope with the necessary invasive evaluations such as intracranial video-eeg monitoring and therefore unsuitable for further pre-surgical assessment. In March 1995, he was implanted with a vagus nerve stimulator. At that time he was treated with carbamazepine and sodium valproate. In the first weeks during ramping up, he complained of hoarseness at the time of stimulation. Within 3 months, there was a reduction of seizure frequency of 50%. Side effects due to stimulation subsided during further ramping up. Since September 1996, the output current of the stimulator has been 2.25 ma. Apart from a temporary decrease of convulsions, there was no further improvement of seizure control despite the initiation of rapid cycle stimulation. Lamotrigine was added to the antiepileptic therapy of the patient in February 1997 at an initial dosage of 25 mg a day and was increased by the same amount every week until reaching a total dosage of 300 mg bid. Shortly after the administration of lamotrigine, when he was on 100 mg bid, the patient became entirely seizure-free. After 12 months of complete seizure-freedom the patient insisted on reducing lamotrigine. During tapering he had two tonic clonic seizures. Therapy was reinstalled and the patient has remained completely seizure-free since.
4 Long-term results of vagus nerve stimulation 331 Table 1: Patient characteristics. Patient no. Initials Sex Age Seizure Duration Follow-up History (years) (months) 1 UP M febrile seizures, head trauma 2 VD F head trauma 3 BI M head trauma 4 VC F encephalitis 5 SP M premature birth, callosotomy 6 HF M febrile seizures 7 VE M head trauma 8 BI F febrile seizures, head trauma 9 JMA F febrile seizures 10 BJ F febrile seizures, encephalitis 11 GL F forceps birth 12 VJC F meningitis, ventricular atrial drainage 13 MG F none 14 VS F none 15 VC M meningitis, head trauma CASE-REPORT # 2 BI is a 39-year-old right-handed man who developed epilepsy at age 23. He had a severe head trauma due to a car accident at age 10. Habitual seizures occurred weekly and began with a strange and indescribable feeling with occasional automatisms followed by deviation of the patient s head to the left and elevation of his left arm. There was loss of consciousness and subsequent secondary generalization. Despite adequate trials with all available AEDs, there was no reduction of seizure frequency. At least once a month, the patient was brought into the emergency room with severe head trauma due to seizures. While being treated with three different AEDs, his maximum seizure-free period was 1 week. At the time of evaluation on the monitoring unit he had four habitual seizures with clinical characteristics suggestive of supplementary motor area onset. The ictal EEG showed a right hemispheric epileptic recruitment; interictally there was diffuse slowing. Optimum MRI revealed bilateral hippocampal signal abnormalities and a left temporal arachnoidal cyst. PET turned out normal. On neuropsychological assessment, the patient presented a disharmonic profile with a frontal dysfunction but no lateralizing signs. Because of the discrepancies between the results of the different pre-surgical tests, the patient was no longer considered a suitable candidate for resective surgery. In September 1995, he was implanted with a vagus nerve stimulator. At the time of implantation he was treated with carbamazepine, sodium valproate and vigabatrin. After the operation he became entirely seizure-free. In June 1996, he experienced a shortlasting CPS after a quarrel with colleagues at work but has remained free of seizures since. Stimulation output current is 1.5 ma. Apart from mild transient hoarseness, the patient did not report any side effects. AED treatment has been unchanged since the implantation. CASE-REPORT # 3 VJC is a 44-year-old right-handed woman who was diagnosed with meningitis complicated by a brain abscess in her right hemisphere at age 8. As a result she developed a partial hemiparesis of the left side of her body and recurrent epileptic seizures. Habitual seizures began with an uncomfortable feeling in her stomach followed by staring and loss of contact for about two minutes. There was a prolonged postictal period of confusion. Despite treatment with several AEDs, she had monthly seizures. Occasionally the patient experienced secondary generalization during night time. Video-EEG monitoring documented CPS with secondary generalization. Ictal onset was located in the right hemisphere but differentiation between temporal or frontal onset could not be made. Interictally, there was irregular slow activity on right-sided frontocentro-temporal electrodes, but there were no focal epileptic discharges. MRI showed right hemispheric porencephaly and gliosis in a large area of the parietal, frontal and temporal lobes on the right side. This was consistent with FDG-PET findings that revealed an ametabolic area in the same region surrounded by a larger hypometabolic area. Because of the extent of the lesion and difficulty in defining the area of ictal onset, the patient was no longer considered a suitable candidate for resective surgery. She was ultimately implanted with a vagus nerve stimulator in October At that time she was treated with lamotrigine. Stimulation was initiated and
5 332 K. Vonck et al. Table 2: Pre-surgical evaluation. Patient no. Interictal EEG Ictal EEG MR PET 1 bil independent sharp and sp/w muscle artifact R hipp atrophy R T hypometab 2 R PT theta activity R ictal recruitment R frontal dysplasia R F hypometab 3 R T theta activity Normal L T arachnoidal cyst bil hipp normal gliosis L > R 4 R TO sp/w bil ictal recruitment normal R T hypometab 5 R T rhytmical theta activity Normal bil frontal signal abn L FP hypometab 6 bil theta & delta activity R ictal recruitment single white matter defect semioval normal center 7 bil theta activity R T ictal recruitment R hipp and cerebellar atrophy R T hypometab 8 L T theta activity L T ictal recruitment normal L PT hypometab 9 normal R T ictalrecruitment R medial T atrophy R hypometab 10 bil post sharp activity R > L T ictal recruitment L posterior hipp structural B PT hypometab abnormality 11 R T sp/w L rhythmicity normal bil L > R F hypometab 12 R FT thet & delta activity R FT recruitment R FT porencephaly R PT ametab hypometab 13 R FT spikes R > L anterior recruitment normal bil T hypometab 14 bil post sp/w bil ictal recruitment bil migration disorder sylvian R T hypometab fissure; polymicrogyri 15 normal RF ictal recruitment F R > L cortical abn gyrus R T hypometab Notation: bil: bilateral; sp/w: spike and wave; R: right, L: left; PT: parietotemporal; T: temporal; TO: temporooccipital; FT: frontotemporal; hipp: hippocampal; abn: abnormality; F: frontal; hypometab: hypometabolism. Table 3: Seizure type, seizure frequency and stimulation output. Patient Seizure type Mean CPS frequency/mth % reduction in SZ Output (ma) no. Pre VNS Post VNS Pre VNS Post VNS frequency 1 CPS + SG / 8 0 a > CPS ± SG/SPS SPS 3 0 a > CPS ± SG / 4 0 a > CPS ± SG CPS ± SG CPS ± SG/SPS CPS ± SG/SPS 4 3 < CPS + SG CPS + SG 4 1 a > CPS ± SG CPS ± SG CPS ± SG/SPS / 4 0 > CPS ± SG CPS ± SG 16 4 a > CPS ± SG CPS ± SG < CPS ± SG CPS 8 2 a > CPS + SG / 2 0 a > CPS ± SG/SPS SPS 200(clusters) 1 day of clusters > CPS + atonic CPS + atonic < CPS CPS 4 1 a >50 3 a Patients with 50% reduction of seizure frequency within 4 months post-implantation. ramped up to an output current of 1.25 ma. Since the implantation, the patient has been completely seizurefree and has experienced no side effects. DISCUSSION VNS is presently used in patients with severe medically refractory epilepsy who are not surgical candidates or who failed resective epilepsy surgery 13, 14. Most implanted patients are adults but a small series of children have been implanted in the context of clinical trials with results comparable to those obtained in adults 12, 15. In the course of an ongoing antiepileptic treatment, it is not always clear which treatment changes are responsible for improvement of seizure control. In our center, none of the patients treated with VNS were included in controlled clinical trials. Hence, adjustment of stimulation parameters and AEDs were at the discretion of the treating physician. Due to the open and descriptive design of this study, the reduction in seizure frequency that was observed in some patients may represent: (a) a true effect of chronic VNS with standard stimulation parameters, (b) an effect of VNS with acute or chronic rapid cycle stimulation, (c) a synergistic effect between VNS and AEDs, (d) a reflection of the natural history of the epilepsy or, (e) more unlikely, a placebo effect. There are very few reports in the literature on the long-term (>2 years) efficacy of chronic VNS 16, 17. Results from these studies indicate that VNS remained
6 Long-term results of vagus nerve stimulation 333 an effective adjunctive therapy for medically refractory partial seizures during a follow-up period of 18 months. A trend towards improved seizure control with longer use of VNS was observed. Response during the first 3 months of treatment seemed predictive of long-term response. Our results are generally in agreement with these findings. All our patients with seizure-free intervals of 12 months or more had an initial reduction of seizure frequency of 50% within 4 months after a vagus nerve stimulator was implanted. Deterioration of seizure frequency after initial improvement was not observed. In the previously published studies, there is no information available on seizure-free patients. More specifically, it is unknown whether reduction of seizure frequency in the first 3 months of treatment heralds seizure freedom in the following months. In this study, the high number of completely seizure-free patients (4/15) does not match with the results of previous large multicentered trials 4 8. While selection bias in our small series is likely, our findings further confirm the previously reported lasting and incremental efficacy of VNS. In our population, patients who gradually improved seemed to have had a gradual effect not only on seizure frequency but on seizure severity as well. In all but two patients, the number and duration of secondary convulsions was decreased when therapeutic output current was reached; half of the patients became completely free of this type of seizures. A subgroup of patients became free of CPS immediately after implantation. The effect the first stimulation trains exert on the vagus nerve and on the underlying epilepsy is presently unclear. Possibly this is the result of an overlap between the effect of anaesthesia or a placebo effect immediately post-operatively and the initiation of stimulation. There are some reports in animal, as well as in human, research on incremental improvement of seizure control when different stimulation parameters are used 12, 18. In our study, alteration to rapid cycle parameters did not result in immediate seizure reduction. However, some of our patients remained on rapid cycle stimulation for several months at which time they did experience improved seizure control. Only prospective randomized trials with cross-over design comparing standard with other stimulation parameters will allow for clinically relevant conclusions about the additional benefit and timing of a particular stimulation mode. Some previous research has suggested that VNS acts through a release of inhibitory neurotransmitters such as GABA and glycine in widespread brain structures 19, 20. Since several AEDs have a similar mode of action, a synergistic effect between VNS and AEDs is not unlikely. In one of our patients, the administration of lamotrigine clearly made the difference. Whether this is due to a synergistic effect with VNS remains to be proven. Further research on the mechanism of action as well as the analysis of a larger patient population will be necessary to identify potentially useful combinations of VNS and specific AEDs. Because of the long history of refractory seizures in our series, long-term seizure freedom in 4/15 patients is unlikely to be due to the natural course of the epilepsy or to a placebo effect that is generally short lasting. The presently available literature and our experience provide little information on how and when to taper medication in responders after implantation of VNS. We tried tapering a single AED in a patient who had been seizure-free for 1 year. This resulted in an immediate recurrence of seizures. Higher baseline seizure rate and later age of epilepsy onset have been reported to be positive predictive factors for outcome 21. In our population we observed quite an opposite trend for baseline seizure frequency. Age of onset was not a predictive factor. Analysis of the clinical characteristics, seizure type(s), results of EEG and imaging studies in the responders and in particular, the seizure-free patients did not reveal consistent findings. Analysis of these characteristics in a larger population of responders versus non-responders is necessary to identify the best candidates for VNS. Only results of large multicentered studies will allow for a more precise patient selection and better estimation of outcome. ACKNOWLEDGEMENTS Supported by grant BO2F and from the Fund for Scientific Research-Flanders. REFERENCES 1. Juul-Jensen, P. and Foldsprang, A. Natural history of epileptic seizures. Epilepsia, 1983; 24: Ward, A. A. Jr. Perspective for surgical therapy of epilepsy. In Epilepsy ARNMD, Ward, A. A., Penry, J. K. and Purpura, eds., 1983; pp New York, Raven Press. 3. Boon, P., De Reuck, J., Calliauw, L. et al. Clinical and neurophysiological correlations in patients with refractory partial seizures and intracranial structural lesions. Acta Neurochrirurgica, 1994; 128: Ben-Menachem, E., Manon-Espaillat, R., Ristanovic, R. et al. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. Epilepsia, 1994; 35: Ramsay, R. E., Uthman, B. M., Augustinsson, L. E. et al. 2. Safety, side-effects and tolerability. Epilepsia, 1994; 35: George, R., Salinsky, M., Kuzniecky, R. et al. Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. Epilepsia, 1994; 35: George, R., Sonnen, A., Upton, A. et al. The vagus nerve stimulation study group. A randomized controlled trial of
7 334 K. Vonck et al. chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology, 1995; 45: Handforth, A., DeGorgio, C. M., Schachter, S. C. et al. Vagus nerve stimulation therapy for partial onset seizures. A randomized, active control trial. Neurology, 1998; 51: Landy, H. J., Ramsay, R. E., Slater, J., Casiano, R. R. and Morgan, R. Vagus nerve stimulation for complex partial seizures: surgical technique, safety and efficacy. Journal of Neurosurgery, 1993; 78: Reid, S. A. Surgical technique for the implantation of the neurocybernetic prosthesis. Epilepsia, 1990; 31 (Suppl. 2): Terry, R., Tarver, B. and Zabara, J. An implantable neurocybernetic prosthesis system. Epilepsia, 1990; 31 (Suppl. 2): Hornig, G. W., Murphy, J. V., Schallert, G. and Tilton, C. Left vagus nerve stimulation in children with refractory epilepsy: an update. Southern Medical Journal, 1997; 90: Stepcic, F. and Jacobson, M. Vagus nerve stimulator: indications and use of the stimulator in clinical practice: results from the postmarketing drug survey (PADS) group. Epilepsia, 1998; 39: Allen, L. S. A prospective postmarketing evaluation of the efficacy of vagus nerve stimulation: postmarketing antiepileptic drugs survey (PADS). Epilepsia, 1998; 39: Murphy, J. V., Hornig, G. and Schallert, G. Left vagal nerve stimulation in children with refractory epilepsy. Archives of Neurology, 1995; 52: Salinsky, M., Uthman, B., Ristanovic, K. et al. The vagus nerve stimulation group. Vagus nerve stimulation for the treatment of medically intractable seizures: results of a 1-year open extension trial. Archives of Neurology, 1996; 53: Holder, L. K., Wernicke, J. F. and Tarver, W. B. Long-term follow-up on 37 patients with refractory partial seizures treated with vagus nerve stimulation. Journal of Epilepsy, 1193; 6: Woodbury, J. W. and Kinghorn, E. W. Vagus nerve stimulation for control of epilepsy in humans: suggested new parameters. Epilepsia, 1998; 39: Woodbury, D. M. and Woodbury, J. W. Effects of vagal stimulation on experimentally induced seizures in rats. Epilepsia, 1990; 31 (Suppl. 2): S7 S Woodbury, J. W. and Woodbury, D. M. Vagal stimulation reduces the severity of maximal electroshock seizures in intact rats: use of cuff electrode for stimulating and recording. Pacing Clinical Electrophysiology, 1991; 14: Labar, D., Murphy, J., Tecoma, E. and Tarver, B. Predictors of seizure rate response to vagus nerve stimulation. Epilepsia, 1998; 39: 92.
Vagus nerve stimulation for refractory epilepsy
Seizure 2001; 10: 456 460 doi:10.1053/seiz.2001.0628, available online at http://www.idealibrary.com on CASE REPORT Vagus nerve stimulation for refractory epilepsy PAUL BOON, KRISTL VONCK, JACQUES DE REUCK
More informationCost-benefit of vagus nerve stimulation for refractory epilepsy Boon P, Vonck K, D'Have M, O'Connor S, Vandekerckhove T, De Reuck J
Cost-benefit of vagus nerve stimulation for refractory epilepsy Boon P, Vonck K, D'Have M, O'Connor S, Vandekerckhove T, De Reuck J Record Status This is a critical abstract of an economic evaluation that
More informationVagal nerve stimulation the Norwegian experience
Seizure 2003; 12: 37 41 doi:10.1016/s1059 1311(02)00138-3 Vagal nerve stimulation the Norwegian experience KARL O. NAKKEN, OLAF HENRIKSEN, GEIR K. RØSTE & RASMUS LOSSIUS The National Centre for Epilepsy,
More informationGenerator replacement in epilepsy patients treated with vagus nerve stimulation
Seizure (2005) 14, 89 99 www.elsevier.com/locate/yseiz Generator in epilepsy patients treated with vagus nerve stimulation Kristl Vonck a, *, Stefanie Dedeurwaerdere a, Liesbeth De Groote a, Vijay Thadani
More informationSurgery for Medically Refractory Focal Epilepsy
Surgery for Medically Refractory Focal Epilepsy Seth F Oliveria, MD PhD The Oregon Clinic Neurosurgery Director of Functional Neurosurgery: Providence Brain and Spine Institute Portland, OR Providence
More informationEpilepsy. Hyunmi Choi, M.D., M.S. Columbia Comprehensive Epilepsy Center The Neurological Institute. Seizure
Epilepsy Hyunmi Choi, M.D., M.S. Columbia Comprehensive Epilepsy Center The Neurological Institute Seizure Symptom Transient event Paroxysmal Temporary physiologic dysfunction Caused by self-limited, abnormal,
More informationEpilepsy: diagnosis and treatment. Sergiusz Jóźwiak Klinika Neurologii Dziecięcej WUM
Epilepsy: diagnosis and treatment Sergiusz Jóźwiak Klinika Neurologii Dziecięcej WUM Definition: the clinical manifestation of an excessive excitation of a population of cortical neurons Neurotransmitters:
More informationPaediatric Epilepsy Update N o r e e n Te a h a n canp C o l e t t e H u r l e y C N S E p i l e p s y
Paediatric Epilepsy Update 2018 N o r e e n Te a h a n canp C o l e t t e H u r l e y C N S E p i l e p s y Epilepsy Service CUH ~550 children New diagnosis-education, support, clinic follow up Epilepsy
More informationThere are several types of epilepsy. Each of them have different causes, symptoms and treatment.
1 EPILEPSY Epilepsy is a group of neurological diseases where the nerve cell activity in the brain is disrupted, causing seizures of unusual sensations, behavior and sometimes loss of consciousness. Epileptic
More informationIntroducing Vagus Nerve Stimulation for Epilepsy
Introducing Vagus Nerve Stimulation for Epilepsy The Most Proven Neuromodulation Therapy For Drug-Resistant Epilepsy Patients VNS Therapy Brochure DSv5.indd 2 26/05/2016 15:31 Drug-Resistant Epilepsy A
More informationNeuromuscular Disease(2) Epilepsy. Department of Pediatrics Soochow University Affiliated Children s Hospital
Neuromuscular Disease(2) Epilepsy Department of Pediatrics Soochow University Affiliated Children s Hospital Seizures (p130) Main contents: 1) Emphasize the clinical features of epileptic seizure and epilepsy.
More information9/30/2016. Advances in Epilepsy Surgery. Epidemiology. Epidemiology
Advances in Epilepsy Surgery George Jallo, M.D. Director, Institute for Brain Protection Sciences Johns Hopkins All Children s Hospital St Petersburg, Florida Epidemiology WHO lists it as the second most
More informationCase reports functional imaging in epilepsy
Seizure 2001; 10: 157 161 doi:10.1053/seiz.2001.0552, available online at http://www.idealibrary.com on Case reports functional imaging in epilepsy MARK P. RICHARDSON Medical Research Council Fellow, Institute
More informationMultimodal Imaging in Extratemporal Epilepsy Surgery
Open Access Case Report DOI: 10.7759/cureus.2338 Multimodal Imaging in Extratemporal Epilepsy Surgery Christian Vollmar 1, Aurelia Peraud 2, Soheyl Noachtar 1 1. Epilepsy Center, Dept. of Neurology, University
More informationEpilepsy. Seizures and Epilepsy. Buccal Midazolam vs. Rectal Diazepam for Serial Seizures. Epilepsy and Seizures 6/18/2008
Seizures and Epilepsy Paul Garcia, M.D. UCSF Epilepsy Epileptic seizure: the physical manifestation of aberrant firing of brain cells Epilepsy: the tendency to recurrent, unprovoked epileptic seizures
More informationTreatment of Epilepsy with Implanted Devices: What Are Indications and Benefits? 11/30/2012
Treatment of Epilepsy with Implanted Devices: What Are Indications and Benefits? 11/30/2012 Barbara C. Jobst, MD Dartmouth-Hitchcock Epilepsy Center Geisel School of Medicine at Dartmouth American Epilepsy
More informationObjectives. Amanda Diamond, MD
Amanda Diamond, MD Objectives Recognize symptoms suggestive of seizure and what those clinical symptoms represent Understand classification of epilepsy and why this is important Identify the appropriate
More informationSeventy percent of patients with epilepsy can be
Neurosurg Focus 32 (3):E12, 2012 Vagal nerve stimulation for the treatment of medically refractory epilepsy: a review of the current literature David E. Connor Jr., D.O., Menarvia Nixon, M.D., Anil Nanda,
More informationEpilepsy & Behavior Case Reports
Epilepsy & Behavior Case Reports 1 (2013) 45 49 Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr Case Report Partial disconnection
More informationCase report. Epileptic Disord 2005; 7 (1): 37-41
Case report Epileptic Disord 2005; 7 (1): 37-41 Periodic lateralized epileptiform discharges (PLEDs) as the sole electrographic correlate of a complex partial seizure Gagandeep Singh, Mary-Anne Wright,
More informationNeuromodulation in Epilepsy. Gregory C. Mathews, M.D., Ph.D.
Neuromodulation in Epilepsy Gregory C. Mathews, M.D., Ph.D. Disclosure There are no disclosures to share with regards to this presentation. Epilepsy Basics What is epilepsy? Partial versus generalized
More informationEpilepsies of Childhood: An Over-view of Treatment 2 nd October 2018
Epilepsies of Childhood: An Over-view of Treatment 2 nd October 2018 Dr Sophia Varadkar MRCPI, PhD Consultant Paediatric Neurologist and Honorary Senior Lecturer Great Ormond Street Hospital for Children
More informationEPILEPSY SURGERY EVALUATION IN ADULTS WITH SCALP VIDEO-EEG MONITORING. Meriem Bensalem-Owen, MD University of Kentucky
EPILEPSY SURGERY EVALUATION IN ADULTS WITH SCALP VIDEO-EEG MONITORING Meriem Bensalem-Owen, MD University of Kentucky DISCLOSURES Received grants for sponsored research as investigator from: UCB Eisai
More informationFocal epilepsy recruiting a generalised network of juvenile myoclonic epilepsy: a case report
Clinical commentary Epileptic Disord 2014; 16 (3): 370-4 Focal epilepsy recruiting a generalised network of juvenile myoclonic epilepsy: a case report Myo Khaing 1,2, Kheng-Seang Lim 1, Chong-Tin Tan 1
More information2007 UCB Pharma SA. All rights reserved. GLOSSARY OF TERMS
2007 UCB Pharma SA. All rights reserved. GLOSSARY OF TERMS Absence Seizure A type of generalised seizure usually seen in children, characterised by transient impairment or loss of consciousness usually
More informationIntracranial Studies Of Human Epilepsy In A Surgical Setting
Intracranial Studies Of Human Epilepsy In A Surgical Setting Department of Neurology David Geffen School of Medicine at UCLA Presentation Goals Epilepsy and seizures Basics of the electroencephalogram
More informationOutcome of Long-Term Vagus Nerve Stimulation for Intractable Epilepsy
Neurol Med Chir (Tokyo) 42, 481 490, 2002 Outcome of Long-Term Vagus Nerve Stimulation for Intractable Epilepsy Kensuke KAWAI, HiroyukiSHIMIZU, TaketoshiMAEHARA, and Hideki MURAKAMI Department of Neurosurgery,
More informationChild Neurology. The Plural. of anecdote. is not evidence. University of Texas Health Science Center at San Antonio
Child Neurology Management of Seizure Disorders The stated goal of advocacy groups for patients with seizures, is to have the patient seizure free. S W Atkinson, MD Management of When to pharmacologically
More information5/22/2009. Pediatric Neurosurgery Pediatric Neurology Neuroradiology Neurophysiology Neuropathology Neuropsychology
Current Surgical Treatment Strategies for the Management of Pediatric Epilepsy University of California, San Francisco Department of Neurological Surgery San Francisco, California Kurtis Ian Auguste, M.D.
More informationIs it epilepsy? Does the patient need long-term therapy?
Is it a seizure? Definition Transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain Is it provoked or unprovoked? Is it epilepsy? Does the
More informationCHILDHOOD OCCIPITAL EPILEPSY OF GASTAUT: A LONG-TERM PROSPECTIVE STUDY
Acta Medica Mediterranea, 2017, 33: 1175 CHILDHOOD OCCIPITAL EPILEPSY OF GASTAUT: A LONG-TERM PROSPECTIVE STUDY MURAT GÖNEN ¹, EMRAH AYTAǹ, BÜLENT MÜNGEN¹ University of Fırat, Faculty of medicine, Neurology
More informationPediatrics. Convulsive Disorders in Childhood
Pediatrics Convulsive Disorders in Childhood Definition Convulsion o A sudden, violent, irregular movement of a limb or of the body o Caused by involuntary contraction of muscles and associated especially
More informationEMG, EEG, and Neurophysiology in Clinical Practice
Mayo School of Continuous Professional Development EMG, EEG, and Neurophysiology in Clinical Practice Matthew T. Hoerth, M.D. Ritz-Carlton, Amelia Island, Florida January 29-February 4, 2017 2016 MFMER
More informationClassification of Seizures. Generalized Epilepsies. Classification of Seizures. Classification of Seizures. Bassel F. Shneker
Classification of Seizures Generalized Epilepsies Bassel F. Shneker Traditionally divided into grand mal and petit mal seizures ILAE classification of epileptic seizures in 1981 based on clinical observation
More informationApproximately 70% of childhood SURGICAL TREATMENTS FOR PEDIATRIC EPILEPSY PROCEEDINGS. Ronald P. Lesser, MD KEY POINTS
ASIM May p153-158 5/14/01 9:19 AM Page 153 SURGICAL TREATMENTS FOR PEDIATRIC EPILEPSY Ronald P. Lesser, MD KEY POINTS Most children with epilepsy refractory to drugs can improve with surgery Temporal lobe
More informationPRESURGICAL EVALUATION. ISLAND OF COS Hippocrates: On the Sacred Disease. Disclosure Research-Educational Grants. Patients with seizure disorders
PRESURGICAL EVALUATION Patients with seizure disorders Gregory D. Cascino, MD Mayo Clinic Disclosure Research-Educational Grants Mayo Foundation Neuro Pace, Inc. American Epilepsy Society American Academy
More informationInterictal High Frequency Oscillations as Neurophysiologic Biomarkers of Epileptogenicity
Interictal High Frequency Oscillations as Neurophysiologic Biomarkers of Epileptogenicity December 10, 2013 Joyce Y. Wu, MD Associate Professor Division of Pediatric Neurology David Geffen School of Medicine
More information*Pathophysiology of. Epilepsy
*Pathophysiology of Epilepsy *Objectives * At the end of this lecture the students should be able to:- 1.Define Epilepsy 2.Etio-pathology of Epilepsy 3.Types of Epilepsy 4.Role of Genetic in Epilepsy 5.Clinical
More informationDiscerning Seizures and Understanding VNS Therapy Delia Nickolaus, CPNP-PC/AC
O U T R E A C H E D U C A T I O N Discerning and Understanding VNS Therapy Delia Nickolaus, CPNP-PC/AC Program Handouts This information is provided as a courtesy by Children's Health Care System and its
More informationNon-lesional Medically-intractable Localization-related Epilepsy Case Presentation December 8, 2013
Non-lesional Medically-intractable Localization-related Epilepsy Case Presentation December 8, 2013 Jennifer L. DeWolfe, DO Associate Professor of Neurology University of Alabama at Birmingham American
More informationAccepted Manuscript. Editorial. Responsive neurostimulation for epilepsy: more than stimulation. Jayant N. Acharya
Accepted Manuscript Editorial Responsive neurostimulation for epilepsy: more than stimulation Jayant N. Acharya PII: S2467-981X(18)30022-2 DOI: https://doi.org/10.1016/j.cnp.2018.06.002 Reference: CNP
More informationErnie Somerville Prince of Wales Hospital EPILEPSY
Ernie Somerville Prince of Wales Hospital EPILEPSY Overview Classification New and old anti-epileptic drugs (AEDs) Neuropsychiatric side-effects Limbic encephalitis Non-drug therapies Therapeutic wishlist
More informationChapter 31-Epilepsy 1. public accountant, and has begun treatment with lamotrigine. In which of the following activities
Chapter 31-Epilepsy 1 Chapter 31. Epilepsy, Self-Assessment Questions 1. BW is a 28-year-old man recently diagnosed with partial seizures. He works as a certified public accountant, and has begun treatment
More informationNeuromodulation in Dravet Syndrome. Eric BJ Segal, MD Director of Pediatric Epilepsy Northeast Regional Epilepsy Group Hackensack, New Jersey
Neuromodulation in Dravet Syndrome Eric BJ Segal, MD Director of Pediatric Epilepsy Northeast Regional Epilepsy Group Hackensack, New Jersey What is neuromodulation? Seizures are caused by synchronized
More informationDiagnosing Complicated Epilepsy: Mapping of the Epileptic Circuitry. Michael R. Sperling, M.D. Thomas Jefferson University Philadelphia, PA
Diagnosing Complicated Epilepsy: Mapping of the Epileptic Circuitry Michael R. Sperling, M.D. Thomas Jefferson University Philadelphia, PA Overview Definition of epileptic circuitry Methods of mapping
More informationContemporary Developments in Childhood Epilepsy Management. Olivia O Mahony, Cork University Hospital, Cork, and Mercy University Hospital
Contemporary Developments in Childhood Epilepsy Management Olivia O Mahony, Cork University Hospital, Cork, and Mercy University Hospital Developments in Epilepsy Care Standardised epilepsy care using
More informationDo seizures beget seizures?
Does MTLE cause progressive neurocognitive damage? Andrew Bleasel Westmead Do seizures beget seizures? The tendency of the disease is toward self-perpetuation; each attack facilitates occurrence of another
More informationIntroduction to seizures and epilepsy
Introduction to seizures and epilepsy Selim R. Benbadis, M.D. Professor Departments of Neurology & Neurosurgery Director, Comprehensive Epilepsy Program Symptomatic seizures Head injury (trauma) Stroke
More informationThis presentation is the intellectual property of the author. Contact them for permission to reprint and/or distribute.
Medically Refractory Epilepsy with a Temporal Lobe Lesion Steven Ellis, MD Neurophysiology Fellow, PGY-5 UT Health San Antonio History No history of febrile seizures, meningitis, encephalitis, or head
More informationRecommendations. for Care of Adults with Epilepsy. Seeking the best treatment from the right doctor at the right time!
Recommendations for Care of Adults with Epilepsy Seeking the best treatment from the right doctor at the right time! Contents This booklet is to help adults and their caregivers know when it is appropriate
More informationElectroencephalography. Role of EEG in NCSE. Continuous EEG in ICU 25/05/59. EEG pattern in status epilepticus
EEG: ICU monitoring & 2 interesting cases Electroencephalography Techniques Paper EEG digital video electroencephalography Dr. Pasiri Sithinamsuwan PMK Hospital Routine EEG long term monitoring Continuous
More informationThe Role of a Vascular Surgeon in the Treatment of Drug Resistant Epilepsy
The Role of a Vascular Surgeon in the Treatment of Drug Resistant Epilepsy Alberto J Lopez MD FACS Assistant Professor of Surgery University of Miami, Jackson Memorial Hospital and VA Medical Center Miami
More informationPeriodic and Rhythmic Patterns. Suzette M LaRoche, MD Mission Health Epilepsy Center Asheville, North Carolina
Periodic and Rhythmic Patterns Suzette M LaRoche, MD Mission Health Epilepsy Center Asheville, North Carolina Continuum of EEG Activity Neuronal Injury LRDA GPDs SIRPIDs LPDs + NCS Burst-Suppression LPDs
More informationManagement of Epilepsy in Primary Care and the Community. Carrie Burke, Epilepsy Specialist Nurse
Management of Epilepsy in Primary Care and the Community Carrie Burke, Epilepsy Specialist Nurse Epilepsy & Seizures Epilepsy is a common neurological disorder characterised by recurring seizures (NICE,
More informationRefractory epilepsy: treatment with new antiepileptic drugs
Seizure 2000; 9: 51 57 doi: 10.1053/seiz.1999.0348, available online at http://www.idealibrary.com on Refractory epilepsy: treatment with new antiepileptic drugs P. K. DATTA & P. M. CRAWFORD Department
More informationIntroduction. 1 person in 20 will have an epileptic seizure at some time in their life
Introduction 1 person in 20 will have an epileptic seizure at some time in their life Epilepsy is diagnosed on the basis of two or more epileptic seizures. Around 450,000 people in the UK have epilepsy
More informationObjectives / Learning Targets: The learner who successfully completes this lesson will be able to demonstrate understanding of the following concepts:
Boone County Fire District EMS Education-Paramedic Program EMS 270 Medical Cases-Seizures Resources Seizures screencast Seizures Flowchart and Seizures Flowchart Video Explanation Objectives / Learning
More informationCandidates for Epilepsy Surgery. Presurgical Evaluation. Presurgical Evaluation. Presurgical Evaluation. Presurgical Evaluation 8/27/2017
PresurgicalEpilepsy Eval: A multidisciplinary approach to intractable epilepsy Tayard Desudchit MD Faculty Of Medicine Chulalongkorn U. Candidates for Epilepsy Surgery Persistent seizures despite appropriate
More informationEarly seizure propagation from the occipital lobe to medial temporal structures and its surgical implication
Original article Epileptic Disord 2008; 10 (4): 260-5 Early seizure propagation from the occipital lobe to medial temporal structures and its surgical implication Naotaka Usui, Tadahiro Mihara, Koichi
More informationPrescribing and Monitoring Anti-Epileptic Drugs
Prescribing and Monitoring Anti-Epileptic Drugs Mark Granner, MD Clinical Professor and Vice Chair for Clinical Programs Director, Iowa Comprehensive Epilepsy Program Department of Neurology University
More informationUpdate in Pediatric Epilepsy
Update in Pediatric Epilepsy Cherie Herren, MD Assistant Professor OUHSC, Department of Neurology September 20, 2018 Disclosures None Objectives 1. Identify common pediatric epilepsy syndromes 2. Describe
More informationA study of 72 children with eyelid myoclonia precipitated by eye closure in Yogyakarta
Neurol J Southeast Asia 2003; 8 : 15 23 A study of 72 children with eyelid myoclonia precipitated by eye closure in Yogyakarta Harsono MD Department of Neurology, Faculty of Medicine, Gadjah Mada University,
More informationAMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY, INC. SUBSPECIALTY CERTIFICATION EXAMINATION IN EPILEPSY MEDICINE
SUBSPECIALTY CERTIFICATION EXAMINATION IN EPILEPSY MEDICINE 2014 Content Blueprint (November 26, 2012) Number of questions: 200 I. Classification 7 9% II. Routine EEG 16 20% III. Evaluation 22 26% IV.
More informationSeizure-Triggered Vagus Nerve Stimulation Using Patient-Specific Seizure Onset Detection
Seizure-Triggered Vagus Nerve Stimulation Using Patient-Specific Seizure Onset Detection Ali Shoeb, Alaa Kharbouch, John Guttag Massachusetts Institute of Technology, Cambridge, MA, USA Trudy Pang, Steven
More informationAn Introduction to VNS Therapy
An Introduction to VNS Therapy Fewer seizures Shorter seizures Faster recovery Why wait?* To Learn More visit VNSTherapy.co.uk 1 *Individual results may vary Are you struggling with uncontrolled seizures?
More informationEpilepsy 101. Overview of Treatment Georgette Smith, PhD, APRN, CPNP. American Epilepsy Society
Epilepsy 101 Overview of Treatment Georgette Smith, PhD, APRN, CPNP American Epilepsy Society Overview of Treatment Rescue Therapies Non-Medication Therapies Epilepsy surgery Vagus nerve stimulation Dietary
More informationAntiepileptic agents
Antiepileptic agents Excessive excitability of neurons in the CNS Abnormal function of ion channels Spread through neural networks Abnormal neural activity leads to abnormal motor activity Suppression
More informationEpilepsy 7/28/09! Definitions. Classification of epilepsy. Epidemiology of Seizures and Epilepsy. International classification of epilepsies
Definitions Epilepsy Dr.Yotin Chinvarun M.D., Ph.D. Seizure: the clinical manifestation of an abnormal and excessive excitation of a population of cortical neurons Epilepsy: a tendency toward recurrent
More information1/31/2009. Paroxysmal, uncontrolled electrical discharge of neurons in brain interrupting normal function
Paroxysmal, uncontrolled electrical discharge of neurons in brain interrupting normal function In epilepsy abnormal neurons undergo spontaneous firing Cause of abnormal firing is unclear Firing spreads
More informationSome epilepsy syndromes are known to be associated with more adverse cognitive consequences than others.
1 Neuropsychology and Epilepsy David W. Loring, Ph.D. Departments of Neurology and Clinical & Health Psychology University of Florida Gainesville, Florida 32610-0236 0236 2 Factors Affecting Cognitive
More informationCase #1. Inter-ictal EEG. Difficult Diagnosis Pediatrics. 15 mos girl with medically refractory infantile spasms 2/13/2010
Difficult Diagnosis Pediatrics Joseph E. Sullivan M.D. Assistant Professor of Clinical Neurology & Pediatrics Director, UCSF Pediatric Epilepsy Center University of California San Francisco Case #1 15
More informationHamartomas and epilepsy: clinical and imaging characteristics
Seizure 2003; 12: 307 311 doi:10.1016/s1059 1311(02)00272-8 Hamartomas and epilepsy: clinical and imaging characteristics B. DIEHL, R. PRAYSON, I. NAJM & P. RUGGIERI Departments of Neurology, Pathology
More informationPrognosis of chronic epilepsy with complex partial
Journal of Neurology, Neurosurgery, and Psychiatry 1984;47:1274-1278 279/83 Prognosis of chronic epilepsy with complex partial seizures D SCHMIDT From the Department ofneurology, University of Berlin,
More informationEpilepsy Surgery: Who should be considered? How will patients do? Bassel Abou-Khalil, M.D.
Epilepsy Surgery: Who should be considered? How will patients do? Bassel Abou-Khalil, M.D. Disclosures none Self-assessment questions Q1- Which qualify for drug resistance in focal epilepsy? A. Failure
More informationDoes a diagnosis of epilepsy commit patients to lifelong therapy? Not always. Here s how to taper AEDs safely and avoid relapse.
Does a diagnosis of epilepsy commit patients to lifelong therapy? Not always. Here s how to taper AEDs safely and avoid relapse. T he epilepsy specialist always has two equally important endpoints in mind
More informationEPILEPSY. New Ideas about an Old Disease. Gregory D. Cascino, MD
EPILEPSY New Ideas about an Old Disease Gregory D. Cascino, MD Disclosure Research-Educational Grants Neuro Pace, Inc. American Epilepsy Society American Academy of Neurology Neurology (Associate Editor)
More informationVNS Therapy Guide. For children and those with special needs with drug-resistant epilepsy
VNS Therapy Guide For children and those with special needs with drug-resistant epilepsy This is the story of little Tony, Buddy and Doc. Teur. Little Tony regularly suffered really bad epileptic seizures
More information1 Atypical absences 2. Drops with arms elevation 3. Nocturnal cluster of spasms and convulsions 4. jerks-
Case 1: James, 14 Infantile onset epilepsy- 1 st seizure soon after vaccination. Infantile spasms, treated with Vigabatrin. AED HISTORY: SVA, TPM, LTG, LEV, CLZ, CBZ. NO STEROIDS Current seizures: 1 Atypical
More informationTo Learn More. An Introduction to VNS Therapy. call or visit VNSTherapy.com
An Introduction to VNS Therapy Fewer seizures. Shorter seizures. Faster recovery. Why wait?* To Learn More call 1-888-867-7846 or visit VNSTherapy.com *Individual results may vary Are you struggling with
More informationSupplementary Online Content
Supplementary Online Content Quek AM, Britton JW, McKeon A, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol. Published online March 26, 2012. doi:10.1001/archneurol.2011.2985.
More informationEpilepsy and intellectual disability a workshop
Epilepsy and intellectual disability a workshop Professor Mike Kerr Institute of psychological medicine and clinical neurosciences, Cardiff University, Wales. UK Aim and structure To understand diagnostic
More informationPresurgical Evaluation before Epilepsy Surgery
Presurgical Evaluation before Epilepsy Surgery Epilepsy Course for Neurology Resident 2015 Kanjana Unnwongse- Wehner, MD Prasat Neurological Epilepsy Center Facts About Epilepsy & Surgery Localization-related
More informationWhat is the Relationship Between Arachnoid Cysts and Seizure Foci?
Epilepsin, 38( 10):1098-1102, 1997 Lippincott-Raven Publishers, Philadelphia 0 International League Against Epilepsy What is the Relationship Between Arachnoid Cysts and Seizure Foci? Santiago Arroyo and
More informationIn our patients the cause of seizures can be broadly divided into structural and systemic causes.
Guidelines for the management of Seizures Amalgamation and update of previous policies 7 (Seizure guidelines, ND, 2015) and 9 (Status epilepticus, KJ, 2011) Seizures can occur in up to 15% of the Palliative
More informationSEIZURE OUTCOME AFTER EPILEPSY SURGERY
SEIZURE OUTCOME AFTER EPILEPSY SURGERY Prakash Kotagal, M.D. Head, Pediatric Epilepsy Cleveland Clinic Epilepsy Center LEFT TEMPORAL LOBE ASTROCYTOMA SEIZURE OUTCOME 1 YEAR AFTER EPILEPSY SURGERY IN ADULTS
More informationSeizure Localization in Patients with Multiple Tubers: Presurgical Evaluation in Tuberous Sclerosis
Seizure Localization in Patients with Multiple Tubers: Presurgical Evaluation in Tuberous Sclerosis Case Report Journal of Epilepsy Research pissn 2233-6249 / eissn 2233-6257 Pamela Song, MD 1, Eun Yeon
More informationEEG workshop. Epileptiform abnormalities. Definitions. Dr. Suthida Yenjun
EEG workshop Epileptiform abnormalities Paroxysmal EEG activities ( focal or generalized) are often termed epileptiform activities EEG hallmark of epilepsy Dr. Suthida Yenjun Epileptiform abnormalities
More informationIdiopathic epilepsy syndromes
1 Idiopathic epilepsy syndromes PANISRA SUDACHAN, M.D. Pe diatric Neuro lo gis t Pediatric Neurology Department Pras at Neuro lo gic al Institute Epilepsy course 20 August 2016 Classification 2 1964 1970
More informationFocal fast rhythmic epileptiform discharges on scalp EEG in a patient with cortical dysplasia
Seizure 2002; 11: 330 334 doi:10.1053/seiz.2001.0610, available online at http://www.idealibrary.com on CASE REPORT Focal fast rhythmic epileptiform discharges on scalp EEG in a patient with cortical dysplasia
More informationEpilepsy 101. Russell P. Saneto, DO, PhD. Seattle Children s Hospital/University of Washington November 2011
Epilepsy 101 Russell P. Saneto, DO, PhD Seattle Children s Hospital/University of Washington November 2011 Specific Aims How do we define epilepsy? Do seizures equal epilepsy? What are seizures? Seizure
More informationACTH therapy for generalized seizures other than spasms
Seizure (2006) 15, 469 475 www.elsevier.com/locate/yseiz ACTH therapy for generalized seizures other than spasms Akihisa Okumura a,b, *, Takeshi Tsuji b, Toru Kato b, Jun Natsume b, Tamiko Negoro b, Kazuyoshi
More informationChosingPhase 2 Electrodes
ChosingPhase 2 Electrodes ACNS Course ECoG/Invasive EEG Houston, February 4 th, 2015 Stephan Schuele, MD, MPH Comprehensive Epilepsy Center Northwestern Memorial Hospital Northwestern University, Feinberg
More informationPediatric Epilepsy Surgery. W. Donald Shields, MD Emeritus Professor of Neurology and Pediatrics David Geffen School of Medicine at UCLA
Pediatric Epilepsy Surgery W. Donald Shields, MD Emeritus Professor of Neurology and Pediatrics David Geffen School of Medicine at UCLA PEDIATRIC EPILEPSY SURGERY A THING OF BEAUTY IF DONE RIGHT PEDIATRIC
More informationSurgery of posterior fossa arachnoid cyst causing hydrocephalus unmasking the cause of epilepsy
CASE REPORTS ALBANIAN MEDICAL JOURNAL Surgery of posterior fossa arachnoid cyst causing hydrocephalus unmasking the cause of epilepsy Florian Dashi 1, Arben Rroji 1, Eugen Enesi 1, Suzana Gjeci 1, Ridvan
More informationEpilepsy. Annual Incidence. Adult Epilepsy Update
Adult Epilepsy Update Annual Incidence J. Layne Moore, MD, MPH Associate Professor Department of Neurology and Pharmacy Director, Division of Epilepsy The Ohio State University Used by permission Health
More informationThe Surgical Treatment of Epilepsy
The Surgical Treatment of Epilepsy Jeffrey S. Schweitzer, MD, PhD Kaiser Los Angeles Medical Center Division of Restorative Neurosurgery Ancient craniotomy When Cao started complaining about splitting
More informationEpilepsy DOJ Lecture Masud Seyal, M.D., Ph.D. Department of Neurology University of California, Davis
Epilepsy DOJ Lecture - 2005 Masud Seyal, M.D., Ph.D. Department of Neurology University of California, Davis Epilepsy SEIZURE: A temporary dysfunction of the brain resulting from a self-limited abnormal
More informationSuccessful treatment of super-refractory tonic status epilepticus with rufinamide: first clinical report
*Manuscript Click here to view linked References Successful treatment of super-refractory tonic status epilepticus with rufinamide: first clinical report Thompson AGB 1, Cock HR 1,2. 1 St George s University
More informationMeasures have been taken, by the Utah Department of Health, Bureau of Health Promotions, to ensure no conflict of interest in this activity
Measures have been taken, by the Utah Department of Health, Bureau of Health Promotions, to ensure no conflict of interest in this activity Seizures in the School Setting Meghan Candee, MD MS Assistant
More informationEpilepsy T.I.A. Cataplexy. Nonepileptic seizure. syncope. Dystonia. Epilepsy & other attack disorders Overview
: Clinical presentation and management Markus Reuber Professor of Clinical Neurology Academic Neurology Unit University of Sheffield, Royal Hallamshire Hospital. Is it epilepsy? Overview Common attack
More information